MENU
EPZM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Epizyme (EPZM) Ownership - Who owns Epizyme?

Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing, and commercializing novel epigenetic medicines... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
400 Technology Square
Phone
+1 617 229-5872
Employees
250
Web
https://www.epizyme.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
247.5M
P/E Ratio
N/A
Total Cash
144.41M
Projected Growth
N/A
Total Debt
237.71M
Revenue
53.01M
Risk (Beta)
-1.31
Dividend Yield
N/A
Total Cash/Share
0.86
Total Debt/Equity
N/A
Revenue/Share
0.41 USD as % of share price
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of therapeutics for the treatment of patients with genetically defined cancers

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
400 Technology Square
Phone
+1 617 229-5872
Employees
250
Web
https://www.epizyme.com